Institutional Ownership
Eyepoint Pharmaceuticals Inc
CUSIP 30233G209COM NEWEYPTQ1 2026
Institutional Holders
180
13F filers
Shares Held
83.21M
Aggregate institutional
Institutional Value
$1.07B
Q1 2026
Net New Holders
+19
41 new · 22 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions41
Increased74
Decreased38
Sold out22
Institutional Holders
180 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 8.30M | $106.94M | +468.7K | Added |
| 2 | Cormorant Asset Management, LP | 8.27M | $106.54M | 0 | Held |
| 3 | Blackrock, Inc. | 7.18M | $92.52M | +389.5K | Added |
| 4 | Federated Hermes, Inc. | 5.67M | $73.08M | −347.8K | Reduced |
| 5 | Franklin Resources Inc | 5.05M | $65.08M | +71.7K | Added |
| 6 | Janus Henderson Group PLC | 3.60M | $46.42M | +663.4K | Added |
| 7 | Adage Capital Partners Gp, L.L.C. | 3.30M | $42.54M | −1.40M | Reduced |
| 8 | Paradigm Biocapital Advisors LP | 3.14M | $40.51M | −549.0K | Reduced |
| 9 | Commodore Capital LP | 2.83M | $36.41M | +2.83M | New |
| 10 | State Street Corp | 2.10M | $27.03M | +262.4K | Added |
170 more institutional holders on Premium
See every fund holding Eyepoint Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders